121 related articles for article (PubMed ID: 25693937)
1. The diagnostic value of DNA hypermethylation in stool for colorectal cancer: a meta-analysis.
Qian LY; Zhang W
J Cancer Res Ther; 2014 Dec; 10 Suppl():287-91. PubMed ID: 25693937
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of secreted frizzled-related protein 2 gene promoter hypermethylation in stool for colorectal cancer: A meta-analysis.
Zhou Z; Zhang H; Lei Y
J Cancer Res Ther; 2016 Oct; 12(Supplement):30-33. PubMed ID: 27721248
[TBL] [Abstract][Full Text] [Related]
3. The value of serum Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung cancer: a meta-analysis.
Cui C; Sun X; Zhang J; Han D; Gu J
J Cancer Res Ther; 2014 Nov; 10 Suppl():C131-4. PubMed ID: 25450270
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of RASSF1A hypermethylation in colorectal cancer: a meta-analysis.
Hu H; Zhou C; Li B; Chen Y; Dai J; Mao Y; Huang T; Yu H; Chen M; Zhao J; Duan S
Pathol Res Pract; 2018 Oct; 214(10):1572-1578. PubMed ID: 30082160
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT.
Bosch LJ; Oort FA; Neerincx M; Khalid-de Bakker CA; Terhaar sive Droste JS; Melotte V; Jonkers DM; Masclee AA; Mongera S; Grooteclaes M; Louwagie J; van Criekinge W; Coupé VM; Mulder CJ; van Engeland M; Carvalho B; Meijer GA
Cancer Prev Res (Phila); 2012 Mar; 5(3):464-72. PubMed ID: 22135045
[TBL] [Abstract][Full Text] [Related]
6. The importance of stool DNA methylation in colorectal cancer diagnosis: A meta-analysis.
Mojtabanezhad Shariatpanahi A; Yassi M; Nouraie M; Sahebkar A; Varshoee Tabrizi F; Kerachian MA
PLoS One; 2018; 13(7):e0200735. PubMed ID: 30024936
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of aberrant gene methylation in stool samples for colorectal cancer or adenomas: a meta-analysis.
Yuan Y; Qu B; Yan J; Wang H; Yin L; Han Q
Panminerva Med; 2015 Jun; 57(2):55-64. PubMed ID: 25256821
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of circulating miR-21 for colorectal cancer: a meta-analysis.
Shan L; Ji Q; Cheng G; Xia J; Liu D; Wu C; Zhu B; Ding Y
Cancer Biomark; 2015; 15(1):47-56. PubMed ID: 25524942
[TBL] [Abstract][Full Text] [Related]
9. Novel methylation panel for the early detection of colorectal tumors in stool DNA.
Azuara D; Rodriguez-Moranta F; de Oca J; Soriano-Izquierdo A; Mora J; Guardiola J; Biondo S; Blanco I; Peinado MA; Moreno V; Esteller M; Capellá G
Clin Colorectal Cancer; 2010 Jul; 9(3):168-76. PubMed ID: 20643622
[TBL] [Abstract][Full Text] [Related]
10. Tumor M2-pyruvate kinase in stool as a biomarker for diagnosis of colorectal cancer: A meta-analysis.
Huang JX; Zhou Y; Wang CH; Yuan WW; Zhang ZD; Zhang XF
J Cancer Res Ther; 2014 Nov; 10 Suppl():C225-8. PubMed ID: 25450288
[TBL] [Abstract][Full Text] [Related]
11. Aberrant methylation of genes in stool samples as diagnostic biomarkers for colorectal cancer or adenomas: a meta-analysis.
Luo YX; Chen DK; Song SX; Wang L; Wang JP
Int J Clin Pract; 2011 Dec; 65(12):1313-20. PubMed ID: 22093539
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of early detection of colorectal tumours by stool methylation markers: a meta-analysis.
Zhang H; Qi J; Wu YQ; Zhang P; Jiang J; Wang QX; Zhu YQ
World J Gastroenterol; 2014 Oct; 20(38):14040-50. PubMed ID: 25320544
[TBL] [Abstract][Full Text] [Related]
13. Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia.
Lidgard GP; Domanico MJ; Bruinsma JJ; Light J; Gagrat ZD; Oldham-Haltom RL; Fourrier KD; Allawi H; Yab TC; Taylor WR; Simonson JA; Devens M; Heigh RI; Ahlquist DA; Berger BM
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1313-8. PubMed ID: 23639600
[TBL] [Abstract][Full Text] [Related]
14. Stool test for colorectal cancer screening: what is going on?
Bonanno E; Rulli F; Galatà G; Pucci S; Sesti F; Farinon AM; Spagnoli LG
Surg Oncol; 2007 Dec; 16 Suppl 1():S43-5. PubMed ID: 18055195
[TBL] [Abstract][Full Text] [Related]
15. Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA.
Han YD; Oh TJ; Chung TH; Jang HW; Kim YN; An S; Kim NK
Clin Epigenetics; 2019 Mar; 11(1):51. PubMed ID: 30876480
[TBL] [Abstract][Full Text] [Related]
16. Stool-based DNA testing, a new noninvasive method for colorectal cancer screening, the first report from Iran.
Abbaszadegan MR; Tavasoli A; Velayati A; Sima HR; Vosooghinia H; Farzadnia M; Asadzedeh H; Gholamin M; Dadkhah E; Aarabi A
World J Gastroenterol; 2007 Mar; 13(10):1528-33. PubMed ID: 17461444
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Value of Fecal MicroRNAs for Colorectal Cancer: a Meta-Analysis.
Wang C; Zhao K; Rong Q
Clin Lab; 2015; 61(12):1845-53. PubMed ID: 26882806
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer.
Carmona FJ; Azuara D; Berenguer-Llergo A; Fernández AF; Biondo S; de Oca J; Rodriguez-Moranta F; Salazar R; Villanueva A; Fraga MF; Guardiola J; Capellá G; Esteller M; Moreno V
Cancer Prev Res (Phila); 2013 Jul; 6(7):656-65. PubMed ID: 23694962
[TBL] [Abstract][Full Text] [Related]
19. Improved fecal DNA test for colorectal cancer screening.
Itzkowitz SH; Jandorf L; Brand R; Rabeneck L; Schroy PC; Sontag S; Johnson D; Skoletsky J; Durkee K; Markowitz S; Shuber A
Clin Gastroenterol Hepatol; 2007 Jan; 5(1):111-7. PubMed ID: 17161655
[TBL] [Abstract][Full Text] [Related]
20. Stool-based DNA tests for colorectal cancer: clinical potential and early results.
Ahlquist DA
Rev Gastroenterol Disord; 2002; 2 Suppl 1():S20-6. PubMed ID: 12439395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
